DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Importantly, the expression of the dystrophin-glycoprotein complex is greatly reduced in dystrophinopathy [23,24,25] resulting in the loss of trans-plasmalemmal linkage in dystrophic skeletal muscles [26].